Trump Administration Proposes Rule to Give Political Appointees Final Say Over Federal Research Grants

The Trump administration has proposed a sweeping overhaul of how the federal government distributes billions of dollars in discretionary grants, aiming to give senior political appointees the final authority over funding decisions. The move represents one of the most significant shifts in federal science and research policy in decades, effectively subordinating independent scientific evaluation to the executive branch's immediate political agenda. If enacted, the rule would fundamentally alter the relationship between the federal government and the thousands of universities, laboratories, and researchers that rely on federal support.[1][2]

Published in the Federal Register on May 29 by the Office of Management and Budget (OMB), the 412-page proposed rule would reclassify the existing "Uniform Guidance" framework into a binding "Uniform Grants Regulation." The core of the proposal mandates a new "pre-issuance review" for all discretionary awards. Under this system, senior political appointees must evaluate and approve grants to ensure they "demonstrably advance the President's policy priorities" before any funds are disbursed. This centralizes grantmaking policy development directly at the OMB, bypassing the traditional agency-by-agency implementation process.[3][5]

A central flashpoint of the proposal is its treatment of scientific peer review—the decades-old system where independent experts evaluate the merit and methodology of research proposals. While the OMB document states that peer review is not explicitly discouraged, it mandates that such recommendations remain strictly "advisory." The rule explicitly forbids political appointees from treating peer review outcomes as "ministerially ratified, routinely deferred to, or otherwise treated as de facto binding." This effectively strips independent scientists of their gatekeeping role, transferring the ultimate decision-making power to administration officials.[3][4]

Beyond structural changes, the regulation attaches a stringent set of ideological conditions to federal funding. The rule explicitly bans federal funds from supporting diversity, equity, and inclusion (DEI) initiatives, "gender ideology," or the "transition of a child under age 19." It also places broad prohibitions on international scientific collaborations, requiring applicants to pass rigorous risk assessments regarding their foreign affiliations. Memberships in certain international organizations and professional dues would require prior, express approval from federal agencies, a hurdle researchers say will paralyze global scientific cooperation.[5][6]

The OMB's proposal does not just apply to future funding; it significantly expands the government's authority to terminate existing grants. Under the amended regulations, federal agencies would be granted the discretion to end funding for ongoing projects if they are deemed to no longer effectuate "program goals, Federal agency priorities, or the national interest as they exist at the time of termination." This "discretionary termination" clause is widely viewed as a response to the legal challenges the administration faced during previous attempts to mass-terminate grants, providing a formalized mechanism to pull funding from projects that fall out of political favor.[3][6]

Proponents of the measure, including OMB Director Russ Vought, argue the overhaul is a necessary step to ensure democratic accountability and align taxpayer spending with the national interest. The administration has frequently criticized federal agencies for funding what it describes as "woke policy agendas" and "anti-American values." By elevating the Uniform Guidance to a binding regulation, the White House asserts that the executive branch can exercise tighter, more transparent control over an entrenched bureaucracy, ensuring that public funds are not weaponized against the administration's stated goals.[7][8]

The scientific and academic communities have mounted a fierce opposition campaign, warning of catastrophic consequences for American innovation. Holden Thorp, editor-in-chief of Science magazine, wrote that the administration appears determined to "mortally wound the nation's scientific enterprise." Advocacy groups like Stand Up for Science have mobilized researchers to lobby Congress, arguing the rule would dismantle the U.S. science ecosystem. Critics point out that the U.S. has historically relied on the insulation of science from partisan politics to maintain its global leadership in research and development.[1][2]

Researchers warn that the practical impacts of the rule could halt critical medical, environmental, and technological advancements overnight. Colette Delawalla, founder of Stand Up for Science, noted that ongoing clinical trials involving international collaboration—such as studies on maternal mental health—could be rendered illegal under the new framework. Furthermore, the academic community fears a severe chilling effect, where scientists will be forced to self-censor their proposals, avoiding vital but politically sensitive topics like climate change, public health, and sociology to appease political reviewers.[1]

Legal experts anticipate a barrage of litigation if the rule is finalized in its current form. Law firms analyzing the proposal note that it includes a severability clause, anticipating that courts might strike down specific ideological bans while leaving the broader structural centralization intact. Meanwhile, in Congress, Democrats have vehemently condemned the rule. Representative Rosa DeLauro characterized the OMB's actions as an attempt to establish a "political test" for lifesaving federal aid, though legislative efforts to block the scheme have so far stalled in committee votes.[5][8]

The public comment period for the proposed rule is scheduled to close on July 13, 2026. Despite a formal request from over 300 multi-sector stakeholders for a 45-day extension to review the massive regulatory package, the OMB appears poised to move forward on its original timeline. If finalized, the sweeping new regulations are slated to take effect on October 1, 2026, applying to all new awards and amendments in Fiscal Year 2027, setting the stage for a historic showdown over the future of American science.[4][5][6]